BEBT-507

N/A

Report date: 2025/04/01 11:31:28
NME

Base Information

Drug NameBEBT-507
Drug Alias NameBEBT-507BEBT507
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceTransmembrane protease serine 6 inhibitors
TargetsTransmembrane protease serine 6
Therapy Area/IndicationsHemochromatosisPolycythemiaPolycythemia Vera
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangzhou BeBetter Medicine Technology Co
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou BeBetter Medicine Technology Co
Inactive CompaniesN/A
Active IndicationsHemochromatosisPolycythemiaPolycythemia Vera
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A